Prenatal Genetic Testing-Europe Market Status and Trend Report 2013-2023
Report Summary
Prenatal Genetic Testing-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Prenatal Genetic Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Prenatal Genetic Testing 2013-2017, and development forecast 2018-2023
Main market players of Prenatal Genetic Testing in Europe, with company and product introduction, position in the Prenatal Genetic Testing market
Market status and development trend of Prenatal Genetic Testing by types and applications
Cost and profit status of Prenatal Genetic Testing, and marketing status
Market growth drivers and challenges
The report segments the Europe Prenatal Genetic Testing market as:
Europe Prenatal Genetic Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Prenatal Genetic Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic Test
Chorionic Villi Sampling (CVS)
Amniocentesis
Placental Biopsy
Cordocentesis
Fetal Biopsy
Screening Test
Carrier Screening
Sequential Screening
Maternal Serum Quad Screening
Europe Prenatal Genetic Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Diagnostic Centers
Europe Prenatal Genetic Testing Market: Players Segment Analysis (Company and Product introduction, Prenatal Genetic Testing Sales Volume, Revenue, Price and Gross Margin):
Sequenom Laboratories
Illumina
Natera
Ariosa Diagnostics
BGI Health
Natera
LifeCodexx
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Prenatal Genetic Testing-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Prenatal Genetic Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Prenatal Genetic Testing 2013-2017, and development forecast 2018-2023
Main market players of Prenatal Genetic Testing in Europe, with company and product introduction, position in the Prenatal Genetic Testing market
Market status and development trend of Prenatal Genetic Testing by types and applications
Cost and profit status of Prenatal Genetic Testing, and marketing status
Market growth drivers and challenges
The report segments the Europe Prenatal Genetic Testing market as:
Europe Prenatal Genetic Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Prenatal Genetic Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic Test
Chorionic Villi Sampling (CVS)
Amniocentesis
Placental Biopsy
Cordocentesis
Fetal Biopsy
Screening Test
Carrier Screening
Sequential Screening
Maternal Serum Quad Screening
Europe Prenatal Genetic Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Diagnostic Centers
Europe Prenatal Genetic Testing Market: Players Segment Analysis (Company and Product introduction, Prenatal Genetic Testing Sales Volume, Revenue, Price and Gross Margin):
Sequenom Laboratories
Illumina
Natera
Ariosa Diagnostics
BGI Health
Natera
LifeCodexx
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PRENATAL GENETIC TESTING
1.1 Definition of Prenatal Genetic Testing in This Report
1.2 Commercial Types of Prenatal Genetic Testing
1.2.1 Diagnostic Test
1.2.2 Chorionic Villi Sampling (CVS)
1.2.3 Amniocentesis
1.2.4 Placental Biopsy
1.2.5 Cordocentesis
1.2.6 Fetal Biopsy
1.2.7 Screening Test
1.2.8 Carrier Screening
1.2.9 Sequential Screening
1.2.10 Maternal Serum Quad Screening
1.3 Downstream Application of Prenatal Genetic Testing
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Diagnostic Centers
1.4 Development History of Prenatal Genetic Testing
1.5 Market Status and Trend of Prenatal Genetic Testing 2013-2023
1.5.1 EMEA Prenatal Genetic Testing Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Genetic Testing Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Prenatal Genetic Testing in EMEA 2013-2017
2.2 Consumption Market of Prenatal Genetic Testing in EMEA by Regions
2.2.1 Consumption Volume of Prenatal Genetic Testing in EMEA by Regions
2.2.2 Revenue of Prenatal Genetic Testing in EMEA by Regions
2.3 Market Analysis of Prenatal Genetic Testing in EMEA by Regions
2.3.1 Market Analysis of Prenatal Genetic Testing in Europe 2013-2017
2.3.2 Market Analysis of Prenatal Genetic Testing in Middle East 2013-2017
2.3.3 Market Analysis of Prenatal Genetic Testing in Africa 2013-2017
2.4 Market Development Forecast of Prenatal Genetic Testing in EMEA 2018-2023
2.4.1 Market Development Forecast of Prenatal Genetic Testing in EMEA 2018-2023
2.4.2 Market Development Forecast of Prenatal Genetic Testing by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Prenatal Genetic Testing in EMEA by Types
3.1.2 Revenue of Prenatal Genetic Testing in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Prenatal Genetic Testing in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Prenatal Genetic Testing in EMEA by Downstream Industry
4.2 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Europe
4.2.2 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Middle East
4.2.3 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Africa
4.3 Market Forecast of Prenatal Genetic Testing in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL GENETIC TESTING
5.1 EMEA Economy Situation and Trend Overview
5.2 Prenatal Genetic Testing Downstream Industry Situation and Trend Overview
CHAPTER 6 PRENATAL GENETIC TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Prenatal Genetic Testing in EMEA by Major Players
6.2 Revenue of Prenatal Genetic Testing in EMEA by Major Players
6.3 Basic Information of Prenatal Genetic Testing by Major Players
6.3.1 Headquarters Location and Established Time of Prenatal Genetic Testing Major Players
6.3.2 Employees and Revenue Level of Prenatal Genetic Testing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PRENATAL GENETIC TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sequenom Laboratories
7.1.1 Company profile
7.1.2 Representative Prenatal Genetic Testing Product
7.1.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Sequenom Laboratories
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Prenatal Genetic Testing Product
7.2.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Natera
7.3.1 Company profile
7.3.2 Representative Prenatal Genetic Testing Product
7.3.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Natera
7.4 Ariosa Diagnostics
7.4.1 Company profile
7.4.2 Representative Prenatal Genetic Testing Product
7.4.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Ariosa Diagnostics
7.5 BGI Health
7.5.1 Company profile
7.5.2 Representative Prenatal Genetic Testing Product
7.5.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of BGI Health
7.6 Natera
7.6.1 Company profile
7.6.2 Representative Prenatal Genetic Testing Product
7.6.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Natera
7.7 LifeCodexx
7.7.1 Company profile
7.7.2 Representative Prenatal Genetic Testing Product
7.7.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of LifeCodexx
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL GENETIC TESTING
8.1 Industry Chain of Prenatal Genetic Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PRENATAL GENETIC TESTING
9.1 Cost Structure Analysis of Prenatal Genetic Testing
9.2 Raw Materials Cost Analysis of Prenatal Genetic Testing
9.3 Labor Cost Analysis of Prenatal Genetic Testing
9.4 Manufacturing Expenses Analysis of Prenatal Genetic Testing
CHAPTER 10 MARKETING STATUS ANALYSIS OF PRENATAL GENETIC TESTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Prenatal Genetic Testing in This Report
1.2 Commercial Types of Prenatal Genetic Testing
1.2.1 Diagnostic Test
1.2.2 Chorionic Villi Sampling (CVS)
1.2.3 Amniocentesis
1.2.4 Placental Biopsy
1.2.5 Cordocentesis
1.2.6 Fetal Biopsy
1.2.7 Screening Test
1.2.8 Carrier Screening
1.2.9 Sequential Screening
1.2.10 Maternal Serum Quad Screening
1.3 Downstream Application of Prenatal Genetic Testing
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Diagnostic Centers
1.4 Development History of Prenatal Genetic Testing
1.5 Market Status and Trend of Prenatal Genetic Testing 2013-2023
1.5.1 EMEA Prenatal Genetic Testing Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Genetic Testing Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Prenatal Genetic Testing in EMEA 2013-2017
2.2 Consumption Market of Prenatal Genetic Testing in EMEA by Regions
2.2.1 Consumption Volume of Prenatal Genetic Testing in EMEA by Regions
2.2.2 Revenue of Prenatal Genetic Testing in EMEA by Regions
2.3 Market Analysis of Prenatal Genetic Testing in EMEA by Regions
2.3.1 Market Analysis of Prenatal Genetic Testing in Europe 2013-2017
2.3.2 Market Analysis of Prenatal Genetic Testing in Middle East 2013-2017
2.3.3 Market Analysis of Prenatal Genetic Testing in Africa 2013-2017
2.4 Market Development Forecast of Prenatal Genetic Testing in EMEA 2018-2023
2.4.1 Market Development Forecast of Prenatal Genetic Testing in EMEA 2018-2023
2.4.2 Market Development Forecast of Prenatal Genetic Testing by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Prenatal Genetic Testing in EMEA by Types
3.1.2 Revenue of Prenatal Genetic Testing in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Prenatal Genetic Testing in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Prenatal Genetic Testing in EMEA by Downstream Industry
4.2 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Europe
4.2.2 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Middle East
4.2.3 Demand Volume of Prenatal Genetic Testing by Downstream Industry in Africa
4.3 Market Forecast of Prenatal Genetic Testing in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL GENETIC TESTING
5.1 EMEA Economy Situation and Trend Overview
5.2 Prenatal Genetic Testing Downstream Industry Situation and Trend Overview
CHAPTER 6 PRENATAL GENETIC TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Prenatal Genetic Testing in EMEA by Major Players
6.2 Revenue of Prenatal Genetic Testing in EMEA by Major Players
6.3 Basic Information of Prenatal Genetic Testing by Major Players
6.3.1 Headquarters Location and Established Time of Prenatal Genetic Testing Major Players
6.3.2 Employees and Revenue Level of Prenatal Genetic Testing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PRENATAL GENETIC TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sequenom Laboratories
7.1.1 Company profile
7.1.2 Representative Prenatal Genetic Testing Product
7.1.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Sequenom Laboratories
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Prenatal Genetic Testing Product
7.2.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Natera
7.3.1 Company profile
7.3.2 Representative Prenatal Genetic Testing Product
7.3.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Natera
7.4 Ariosa Diagnostics
7.4.1 Company profile
7.4.2 Representative Prenatal Genetic Testing Product
7.4.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Ariosa Diagnostics
7.5 BGI Health
7.5.1 Company profile
7.5.2 Representative Prenatal Genetic Testing Product
7.5.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of BGI Health
7.6 Natera
7.6.1 Company profile
7.6.2 Representative Prenatal Genetic Testing Product
7.6.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of Natera
7.7 LifeCodexx
7.7.1 Company profile
7.7.2 Representative Prenatal Genetic Testing Product
7.7.3 Prenatal Genetic Testing Sales, Revenue, Price and Gross Margin of LifeCodexx
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL GENETIC TESTING
8.1 Industry Chain of Prenatal Genetic Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PRENATAL GENETIC TESTING
9.1 Cost Structure Analysis of Prenatal Genetic Testing
9.2 Raw Materials Cost Analysis of Prenatal Genetic Testing
9.3 Labor Cost Analysis of Prenatal Genetic Testing
9.4 Manufacturing Expenses Analysis of Prenatal Genetic Testing
CHAPTER 10 MARKETING STATUS ANALYSIS OF PRENATAL GENETIC TESTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference